Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36(7):1720–48. https://doi.org/10.1038/s41375-022-01620-2.
Article PubMed PubMed Central Google Scholar
Clark J, Kowlessur M, VanderVeer E, Shojania K, Au S, Kim H, et al. Hematologic malignancies masquerading as rheumatologic diseases: a case series and review. Medicine (Baltimore). 2025;104(17): e42251. https://doi.org/10.1097/md.0000000000042251.
Karube K, Scarfò L, Campo E, Ghia P. Monoclonal B cell lymphocytosis and in situ lymphoma. Semin Cancer Biol. 2014;24:3–14. https://doi.org/10.1016/j.semcancer.2013.08.003.
Rezk SA, Weiss LM. EBV-Associated lymphoproliferative disorders: update in classification. Surg Pathol Clin. 2019;12(3):745–70. https://doi.org/10.1016/j.path.2019.03.002.
Moosic KB, Ananth K, Andrade F, Feith DJ, Darrah E, Loughran TP Jr. Intersection between large granular lymphocyte leukemia and rheumatoid arthritis. Front Oncol. 2022;12: 869205. https://doi.org/10.3389/fonc.2022.869205.
Article PubMed PubMed Central Google Scholar
Royer B, Cazals-Hatem D, Sibilia J, Agbalika F, Cayuela JM, Soussi T, et al. Lymphomas in patients with Sjogren’s syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood. 1997;90(2):766–75.
Nocturne G, Pontarini E, Bombardieri M, Mariette X. Lymphomas complicating primary Sjögren’s syndrome: from autoimmunity to lymphoma. Rheumatology (Oxford). 2021;60(8):3513–21. https://doi.org/10.1093/rheumatology/kez052.
Ganapathi KA, Brown LE, Prakash S, Bhargava P. New developments in non-Hodgkin lymphoid malignancies. Pathology. 2021;53(3):349–66. https://doi.org/10.1016/j.pathol.2021.01.002.
Gaddey HL, Riegel AM. Unexplained lymphadenopathy: evaluation and differential diagnosis. Am Fam Physician. 2016;94(11):896–903.
Calgüneri M, Oztürk MA, Ozbalkan Z, Akdogan A, Ureten K, Kiraz S, et al. Frequency of lymphadenopathy in rheumatoid arthritis and systemic lupus erythematosus. J Int Med Res. 2003;31(4):345–9. https://doi.org/10.1177/147323000303100415.
Hasegawa M, Sakai F, Konda N, Okabayashi A, Katsura H, Seto Y. CT assessment of axillary lymphadenopathy in patients with rheumatoid arthritis: association with disease activity and severity. Rheumatol Int. 2018;38(6):1017–22. https://doi.org/10.1007/s00296-018-3992-6.
Wick MR, O’Malley DP. Lymphadenopathy associated with IgG4-related disease: diagnosis & differential diagnosis. Semin Diagn Pathol. 2018;35(1):61–6. https://doi.org/10.1053/j.semdp.2017.11.006.
Rodolfi S, Della-Torre E, Bongiovanni L, Mehta P, Fajgenbaum DC, Selmi C. Lymphadenopathy in the rheumatology practice: a pragmatic approach. Rheumatology (Oxford). 2024;63(6):1484–93. https://doi.org/10.1093/rheumatology/kead644.
Okabe Y, Aoki T, Terasawa T, Kinoshita S, Nakayamada S, Tanaka Y, et al. Mediastinal and axillar lymphadenopathy in patients with rheumatoid arthritis: prevalence and clinical significance. Clin Imaging. 2019;55:140–3. https://doi.org/10.1016/j.clinimag.2019.02.014.
Sève P, Pacheco Y, Durupt F, Jamilloux Y, Gerfaud-Valentin M, Isaac S, et al. Sarcoidosis: a clinical overview from symptoms to diagnosis. Cells. 2021. https://doi.org/10.3390/cells10040766.
Article PubMed PubMed Central Google Scholar
Giacomelli R, Ruscitti P, Shoenfeld Y. A comprehensive review on adult onset still’s disease. J Autoimmun. 2018;93:24–36. https://doi.org/10.1016/j.jaut.2018.07.018.
McCurley TL, Collins RD, Ball E, Collins RD. Nodal and extranodal lymphoproliferative disorders in Sjogren’s syndrome: a clinical and immunopathologic study. Hum Pathol. 1990;21(5):482–92. https://doi.org/10.1016/0046-8177(90)90004-o.
Subramaniam K, D’Rozario J, Pavli P. Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: a review. J Gastroenterol Hepatol. 2013;28(1):24–30. https://doi.org/10.1111/jgh.12015.
Askling J, Brandt L, Lapidus A, Karlén P, Björkholm M, Löfberg R, et al. Risk of Haematopoietic cancer in patients with inflammatory bowel disease. Gut. 2005;54(5):617–22. https://doi.org/10.1136/gut.2004.051771.
Article PubMed PubMed Central Google Scholar
Hori Y, Yamamoto H, Kawatoko S, Nozaki Y, Torisu T, Kato K, et al. Lymphoid and myeloid proliferative disorders associated with inflammatory bowel disease: a clinicopathological study of 15 cases. Hum Pathol. 2022;120:88–98. https://doi.org/10.1016/j.humpath.2021.12.010.
Perera J, Delrosso CA, Nerviani A, Pitzalis C. Clinical phenotypes, serological biomarkers, and synovial features defining seropositive and seronegative rheumatoid arthritis: A literature review. Cells. 2024;13(9). https://doi.org/10.3390/cells13090743.
De Stefano L, D’Onofrio B, Gandolfo S, Bozzalla Cassione E, Mauro D, Manzo A, et al. Seronegative rheumatoid arthritis: one year in review 2023. Clin Exp Rheumatol. 2023;41(3):554–64. https://doi.org/10.55563/clinexprheumatol/go7g26.
Dibrov DA, Avdeeva AS, Rybakova VV, Demidova NV, Nasonov EL. Clinical features of ACPA-negative and ACPA-positive variants of rheumatoid arthritis. Dokl Biochem Biophys. 2024;517(1):243–9. https://doi.org/10.1134/s1607672924700996.
Du L, Wang P, Liu C, Li S, Yue S, Yang Y. Multisystemic manifestations of IgA vasculitis. Clin Rheumatol. 2021;40(1):43–52. https://doi.org/10.1007/s10067-020-05166-5.
Hesford J, Medford AR, Gunawardena H. Lessons of the month: ANCA-associated vasculitis - granulomatosis with polyangiitis: ‘the great mimic’. Clin Med (Lond). 2021;21(2):e231–3. https://doi.org/10.7861/clinmed.2020-1037.
Springer JM, Villa-Forte A. Vasculitis mimics and other related conditions. Rheum Dis Clin North Am. 2023;49(3):617–31. https://doi.org/10.1016/j.rdc.2023.03.008.
Du J, Wang H, Zhang L, Li H, Li S, Zhang C, et al. Axillary lymphadenopathy as the initial manifestation in ANCA-associated systemic vasculitis: a case report. Medicine. 2023;102(29): e34218. https://doi.org/10.1097/md.0000000000034218.
Article PubMed PubMed Central Google Scholar
Quinn KA, Gribbons KB, Carette S, Cuthbertson D, Khalidi NA, Koening CL, et al. Patterns of clinical presentation in Takayasu’s arteritis. Semin Arthritis Rheum. 2020;50(4):576–81. https://doi.org/10.1016/j.semarthrit.2020.04.012.
Article PubMed PubMed Central Google Scholar
Greco A, De Virgilio A, Ralli M, Ciofalo A, Mancini P, Attanasio G, et al. Behçet’s disease: new insights into pathophysiology, clinical features and treatment options. Autoimmun Rev. 2018;17(6):567–75. https://doi.org/10.1016/j.autrev.2017.12.006.
Kötter I, Lötscher F. Behçet’s syndrome apart from the triple symptom complex: vascular, neurologic, gastrointestinal, and musculoskeletal manifestations. Mini Rev Front Med (Lausanne). 2021;8:639758. https://doi.org/10.3389/fmed.2021.639758.
Hernández-Rodríguez J, Alba MA, Prieto-González S, Cid MC. Diagnosis and classification of polyarteritis nodosa. J Autoimmun. 2014;48:84–9. https://doi.org/10.1016/j.jaut.2014.01.029.
Wolff L, Horisberger A, Moi L, Karampetsou MP, Comte D. Polyarteritis nodosa: old disease, new etiologies. Int J Mol Sci. 2023. https://doi.org/10.3390/ijms242316668.
Comments (0)